Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2007
11/29/2007WO2007134867A2 Treating muscular disorders and improving muscular function
11/29/2007WO2007134819A1 Cationic liposomal preparations for the treatment of rheumatoid arthritis
11/29/2007WO2007134538A1 Rat antihuman macrophage migration inhibitory factor monoclonal antibody and its application
11/29/2007WO2007112204A3 Ingestible compositions containing extracts
11/29/2007WO2007042241A3 Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications
11/29/2007US20070276046 Alpha-Aminoamide Derivatives Useful as Anti-Inflammatory Agents
11/29/2007US20070276043 3-(p-Substituted alkoxyphenyl)-2-(o-benzoylanilino)propionic acid derivatives, e.g., 2-(o-Benzoylphenylamino)-3-(p-{2-[(o-fluorophenyl)isobutylamino]-ethoxy}phenyl)propionic acid; for treating non-insulin dependent diabetes and obesity
11/29/2007US20070276040 Peptidyl Arginine Deiminase Type IV Inhibitor
11/29/2007US20070275995 Thiobenzimidazole derivatives
11/29/2007US20070275938 1-Alpha, 3-beta, 17-beta-trihydroxy-4 alpha-fluoroandrost-5-ene; cystic fibrosis, neutropenia, rheumatoid arthritis
11/29/2007US20070275937 1-Alpha, 3-beta, 17-beta-trihydroxy-4 alpha-fluoroandrost-5-ene; cystic fibrosis, neutropenia, rheumatoid arthritis
11/29/2007US20070275932 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
11/29/2007US20070275931 Bisphosphonate compounds and methods
11/29/2007US20070275910 Phosphoramidate Derivatives
11/29/2007US20070275895 Inhibiting proliferation of immune cells in leukemia comprising administering an antibody that specifically binds a follistatin-3 polypeptide; inhibiting B cell or T cell proliferation
11/29/2007US20070275095 Treatment of inflammatory, autoimmune, or other disorders, using agents that reduce the sequestering of zinc by calprotectin
11/29/2007US20070275032 Use Of A Mixture For The Production Of An Agent For Treating Defective Or Degenerated Cartilage In The Production Of Natural Cartilage Replacement In Vitro
11/29/2007US20070275028 Injectable fibrin composition for bone augmentation
11/29/2007US20070275004 Group b streptococcus antigens
11/29/2007US20070274993 Immunocompetent Cell Activation Inhibitor and Use Thereof
11/29/2007US20070274977 Methods for Lowering Elevated Uric Acid Levels Using Intravenous Injections of PEG-Uricase
11/29/2007US20070274974 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/29/2007CA2652537A1 Veterinary pharmaceutical compositions for the treatment of pain and inflammation
11/28/2007EP1858355A1 High pressure processing of metal ion lactoferrin
11/28/2007EP1723157B1 Amorphous forms of risedronate monosodium
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007CN101080403A Novel hydantoin derivatives as metalloproteinase inhibitors
11/28/2007CN101080402A Hydantoin derivatives useful as metalloproteinase inhibitors
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN101077393A Shoushen shenbao' granule
11/28/2007CN101077375A External application pain-relieving anti-inflammation traditional Chinese medicine for treating injuries from falls and rheumatisants
11/28/2007CN101077367A Zhuang medicine medicinal liquor for treating bone injury
11/28/2007CN101077344A Infusion preparation of ibuprofen and preparation method thereof
11/28/2007CN101077343A Dexibuprofen granule and preparation method thereof
11/28/2007CN101077108A Health-care tea and its preparing process
11/28/2007CN100351263C Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
11/28/2007CN100351261C Crystalline glucosamine sulphate metal salts and its preparation method
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351248C Genistein derivatives and their preparation process and use
11/28/2007CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/28/2007CN100351244C Bis-aromatic alkanols
11/28/2007CN100351237C Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
11/28/2007CN100350971C Stimulation of bone growth with thrombin peptide derivatives
11/28/2007CN100350963C Compound saffron oil and its production technology
11/28/2007CN100350959C External remedy for treating hyperosteogeny
11/28/2007CN100350938C Traditional Chinese herbal medicine preparation for curing hyperosteogeny
11/28/2007CN100350906C Dichlofenas sodium slow release suppository and its preparation method
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/27/2007US7301022 N-(2-(6-7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-ylamino)pyrimidin-4-yl)-5-(trifluoromethyl)phenyl)-1-isopropylpyrrolidine-2-carboxamide hydrochloride; antiinflammatory agents, analgesics, antiarthritic agents, antiulcer agents
11/27/2007US7301005 Immunomodulatory peptides derived from heat shock proteins and uses thereof
11/27/2007US7300952 NF-κb inhibitors
11/27/2007US7300934 carbocyclic carboxy nitriles such as 4-chloro-N-[2-({[(1S)-1-cyano-2-thien-3-ylethyl]amino}carbonyl)cyclohexyl]benzamide, used as cathepsin inhibitors; antimetastatic and antitumor agents; prophylaxis of cardiovascular and bone disorders
11/27/2007US7300925 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3
11/27/2007US7300919 Pulmonary delivery of active fragments of parathyroid hormone
11/27/2007US7300916 Use of an erythropoietin antagonist for manufacture of a pharmaceutical preparation for preventing and/or treating hypertrophic scars, keloid or chronic arthritic diseases.
11/27/2007CA2391333C Sustained release formulation of a peptide and a copolymer
11/27/2007CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132947A1 Bcl-xL TRANSGENIC ANIMAL AND UTILIZATION OF THE SAME
11/22/2007WO2007132945A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132714A1 Agent for increasing bone density
11/22/2007WO2007132307A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007WO2007132138A1 Pharmaceutically acceptable salts and polymorphic forms
11/22/2007WO2007131991A1 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
11/22/2007WO2007131546A1 Hyaluronic acid binary mixtures and therapeutic use thereof
11/22/2007WO2007131424A1 Method for preparing low molecular weight proteoglycan and collagen compositions, its products and uses
11/22/2007WO2007113451A3 Process for extracting mother-of-pearl molecules, compositions and use
11/22/2007WO2007099432A3 Pharmaceutical composition containing butea isoflavones for the prevention /treatment of bone disorders and a process for the preparation thereof
11/22/2007WO2007093183A3 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/22/2007WO2007046123A3 Composition containing vitamins k and d as well as taurine for the preventio and treatment of osteoporosis
11/22/2007US20070270490 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
11/22/2007US20070270489 Remedy for Cartilage-Related Diseases
11/22/2007US20070270453 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
11/22/2007US20070270446 Reversed Pyrimidinone Compounds as Calcilytics
11/22/2007US20070270441 Combination
11/22/2007US20070270431 Preventive and/or Therapeutic Medicine for Rheumatoid Arthritis
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070270388 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
11/22/2007US20070270376 Combinations of Hyaluronic Acid and Polyunsaturated Fatty Acids
11/22/2007US20070270350 Methods and Compositions for the Prevention and Treatment of Inflammatory Diseases or Conditions
11/22/2007US20070270341 Parathyroid hormone analogues and methods of use
11/22/2007US20070270337 Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
11/22/2007US20070270334 Polypeptide-dimers for use in treatment and prevention of infection, bone, blood, eating, tumor, autoimmune and inflammatory disorders
11/22/2007US20070269538 Method for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs
11/22/2007US20070269413 Transdiscal administration of high affinity anti-MMP inhibitors
11/22/2007US20070269411 Porous silicon materials and devices
11/22/2007US20070269372 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
11/22/2007DE102005014080B4 Additionssalze des Tolperison, Verfahren zu deren Herstellung, Verwendung derselben und diese enthaltende Arzneimittel Addition salts of tolperisone, processes for their manufacture, use thereof and pharmaceutical compositions containing them
11/22/2007CA2651791A1 Methods for treating autoimmune diseases using a taci-ig fusion molecule
11/22/2007CA2651629A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007CA2651039A1 Hyaluronic acid binary mixtures and therapeutic use thereof
11/22/2007CA2649489A1 Pharmaceutically acceptable salts and polymorphic forms
11/21/2007EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857465A1 Method of producing protein by using hamster igf-1
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1856040A2 Novel lipoxygenase inhibitors
11/21/2007EP1855674A2 Composition for inhibition of cathepsin k
11/21/2007EP1855673A2 Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders
1 ... 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 ... 820